Related Experiment Video
Updated: Jul 10, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
Sandra J Bliss1, Katherine L O'Brien, Edward N Janoff
1Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. sandrajbliss@yahoo.com
Insights
Pneumococcal conjugate vaccines (PCVs) offer significant protection against serious pneumococcal infections in infants with HIV. Vaccination also benefits HIV-infected adults indirectly by reducing disease spread in the community.
Area of Science:
- Pediatrics
- Infectious Diseases
- Vaccinology
Background:
- HIV-infected children face a substantially higher risk of severe pneumococcal infections.
- Pneumococcal infections are a leading cause of morbidity and mortality in this vulnerable population.
Purpose of the Study:
- To review the burden of pneumococcal disease in HIV-infected children.
- To evaluate the safety and efficacy of pneumococcal conjugate vaccines (PCVs) in this group.
Main Methods:
- Systematic review of available data on pneumococcal disease epidemiology.
- Analysis of clinical trial and observational data on PCV safety and effectiveness in HIV-infected children.
Main Results:
- PCVs cover most serotypes responsible for invasive pneumococcal disease (IPD) in HIV-infected individuals.
- PCVs demonstrate substantial efficacy in preventing IPD and pneumonia in HIV-infected infants.
- Community vaccination of children provides indirect protection to HIV-infected adults.
Conclusions:
- Pneumococcal conjugate vaccines are a crucial intervention for improving health outcomes in HIV-infected children.
- Widespread PCV use contributes to reducing the burden of pneumococcal disease in both vaccinated children and the wider community.
Abstract:
Pneumococcal conjugate vaccines (PCVs) are a potentially useful complement to existing treatment strategies in HIV-infected children, for whom pneumococcal infections are common and serious. This Review summarises available data on the burden of pneumococcal disease and the safety and efficacy of PCVs in HIV-infected children. The data demonstrate that children with HIV have significantly increased risk of pneumococcal disease compared with uninfected children; the serotypes included in currently licensed or near-licensure conjugate vaccines include most serotypes that cause invasive pneumococcal disease (IPD) in HIV-infected children and adults; PCVs provide substantial protection against IPD and clinical pneumonia when given to HIV-infected infants; and HIV-infected adults gain an indirect benefit when children in the community are vaccinated. PCV should be considered as an important intervention for improving the lives of HIV-infected children.
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Respiratory Syncytial Virus Disease
Vaccinations
Poliomyelitis
Cryptococcal Meningitis
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

